Here, we have used a proteomics strategy based on mass spectrometry analysis of immuno-precipitated protein complexes and chromatin as well as expression modulation using CRISPR/dCAS9 to decipher the composition of PRC1 complexes and to characterize the BMI1 interactome in GBM. Here, BMI1 is linked to glioblastoma.